Kyowa Kirin Receives Positive CHMP Opinion for the Self-administration of CRYSVITA® ? (burosumab) to Treat X-Linked Hypophosphataemia (XLH), a Rare Metabolic Bone Disorder
Self-administration of CRYSVITA could offer additional options for healthcare professionals to meet the needs of…